Heron et al. (84) and Bretagne et al. (85) show a significant decrease in the CD103+CD4+/CD4+ ratio in sarcoidosis patients in comparison to other ILD while a study by Hyldgaard et al. (79) does not show a similar decrease. This evidence concerns the gene ITGAE and interstitial lung disease.